In short the two studies are very different in design. Firstly study Geno 003 Phase I was in HSV-2 positive people whereas ours was in HSV-2 negative people so we couldn’t compare viral shedding numbers. Our next study will be in these positive people.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.70 |
Change
-0.290(4.84%) |
Mkt cap ! $88.34M | |||
| Open | High | Low | Value | Volume |
| $6.00 | $6.28 | $5.70 | $96.98K | 16.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 175 | $5.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.80 | 360 | 1 |
View Market Depth
| Last trade - 15.49pm 02/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |